Hemostatic Applicator Release Mechanism for Stable Wound Contact

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing hemostatic agents are inefficiently applied during surgical procedures, leading to potential dislodgement and re-bleeding due to manual placement and maintenance issues, especially in laparoscopic and endoscopic surgeries where visualization and access are limited.

Innovation Solution

A hemostatic agent applicator with a handle and actuators that allow precise delivery and release of hemostatic components, ensuring accurate placement and sustained pressure on the wound, featuring a delivery component that can be attached to the wound and released using actuators.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of operation

If manual application of hemostatic agents is used, then the procedure is simple and requires minimal equipment, but the directionality and accuracy of placement deteriorates and maintenance of position over bleeding tissue becomes difficult

Engineering Contradiction:
Improvesimplicity of applicationVSAvoidaccuracy of placement
Core Design Contradiction:
Ease of operationVSManufacturing precision

Solution Approach 1:

A delivery device acts as an intermediary between the surgeon and the hemostatic agent, providing a structured platform that ensures accurate placement. The device includes a delivery component with a base and protrusions that interface with the tissue, allowing precise positioning while the surgeon maintains control through the handle.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The delivery device is segmented into distinct functional components: a handle for control, a delivery component for placement, and the hemostatic agent itself. This segmentation allows each component to be optimized for its specific function while maintaining overall system simplicity.

Inventive Principle:
Principle #1Segmentation

2Ease of operation

If manual pressure is applied to maintain hemostatic agent position, then direct control is possible, but dislodgement occurs when pressure is released leading to re-bleeding

Engineering Contradiction:
Improvedirect controlVSAvoidmaintenance of position
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The delivery component is designed to maintain its own position on the tissue through geometric interlocking features. The protrusions engage with corresponding features on the tissue or underlying structures, allowing the device to self-maintain position without continuous manual pressure from the surgeon.

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The device transitions from a controlled state during application to a self-sustaining state after deployment. The mechanical features are designed to engage and lock into position, providing dynamic stability that maintains the hemostatic agent in place throughout the clotting process.

Inventive Principle:
Principle #15Dynamics

3Productivity

If hemostatic agents are applied without confinement to target tissue, then application is faster, but waste occurs and ineffective positioning leads to failure to control bleeding

Engineering Contradiction:
Improvespeed of applicationVSAvoidwaste of hemostatic agent
Core Design Contradiction:
ProductivityVSLoss of substance

Solution Approach 1:

The delivery component is designed with specific geometric features including a base and protrusions that concentrate the hemostatic agent precisely at the target site. This localized delivery ensures the agent is confined to the bleeding area, preventing waste while maintaining fast application through the pre-positioned delivery mechanism.

Inventive Principle:
Principle #3Local quality

4Reliability

If continuous manual pressure is used to maintain hemostasis, then hemostatic agent position is stabilized, but the procedure becomes time-consuming and requires sustained surgeon attention

Engineering Contradiction:
Improvestability of hemostatic agentVSAvoidtime for pressure maintenance
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The device provides sufficient mechanical stabilization through its geometric features that partial engagement is adequate to maintain position. The protrusions and base design create enough mechanical interlocking to stabilize the hemostatic agent without requiring excessive or continuous manual pressure, reducing the time burden on the surgeon.

Inventive Principle:
Principle #16Partial or excessive action

Data Source

PatentUS12539405B2Hematostick/HematoDart
Publication Date: 2026.02.03 INST FOR CANCER RES D B A THE RES INSTITUE OF FOX CHASE CANCER CENT
  • US12539405B2 patent drawing
  • US12539405B2 patent drawing

AI summary

The present disclosure provides hemostatic agent applicators configured to deliver hemostatic agents to an internal or external bleeding surface for promoting the clotting of blood, and to methods of using the applicator, and to kits comprising the applicator.